دورية أكاديمية

Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference, Albufeira, 25–28 March 2015

التفاصيل البيبلوغرافية
العنوان: Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference, Albufeira, 25–28 March 2015
المؤلفون: Verkman, Alan S., Edelman, Aleksander, Amaral, Margarida, Mall, Marcus A., Beekman, Jeffrey M., Meiners, Torsten, Galietta, Luis J.V., Bear, Christine E.
المصدر: Journal of cystic fibrosis, 14(6): 700–705
سنة النشر: 2015
المجموعة: Publisso (ZB MED-Publikationsportal Lebenswissenschaften)
الوصف: Cystic fibrosis (CF) has a complex and chronic manifestation, with the severity and types of symptoms differing widely from person to person depending on their specific genetic mutation, their environment and their genetic background. Individuals with CF have treatment plans aimed at ameliorating the debilitating symptoms of their disease, including difficulties in breathing, recurrent lung infections and digestive disorders. The year 2012 marked a turning point for certain eligible CF patients — KALYDECO™ was approved as a therapy for a small group of CF patients exhibiting the G551D mutation [1] and eight other rare CFTR mutations in the CFTR gene.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://repository.publisso.de/resource/frl:6402315Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786369Test/; http://dx.doi.org/10.1016/j.jcf.2015.10.001Test
DOI: 10.1016/j.jcf.2015.10.001
الإتاحة: https://doi.org/10.1016/j.jcf.2015.10.001Test
https://repository.publisso.de/resource/frl:6402315Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786369Test/
رقم الانضمام: edsbas.7AFF56FD
قاعدة البيانات: BASE